Efg Capital International Corp. Legend Biotech Corp Transaction History
Efg Capital International Corp.
- $432 Billion
- Q2 2023
A detailed history of Efg Capital International Corp. transactions in Legend Biotech Corp stock. As of the latest transaction made, Efg Capital International Corp. holds 6,834 shares of LEGN stock, worth $271,651. This represents 0.11% of its overall portfolio holdings.
Number of Shares
6,834Holding current value
$271,651% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding LEGN
# of Institutions
225Shares Held
74.3MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$444 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$298 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$264 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$227 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$200 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.65B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...